TestAVec is sponsoring a PhD position at Anglia Ruskin University. The Vice-Chancellor’s Studentship, match-funded by TestAVec, is currently live with a submission deadline of 8th February 2026 . This research programme focuses on developing a CAR-T model of genotoxicity using induced pluripotent stem cells (iPSCs) and TestAVec’s patented hInGeTox™ suite of assays. The successful candidate will develop key cell-culture skills, including differentiation and characterisation of

Merry Christmas and happy new year to all from the TestAVec team. We hope you have a wonderful break and look forward to working together in 2026.

The TestAVec team will be at the ESGCT between 7-10th October 2025, in Seville, Spain. The annual European congress on cell and gene...

The TestAVec team is pleased to announce that the peer reviewed research article on hingetox has been published in Nature Gene Therapy....

TestAVec researchers, lead by CSO Michael Themis, have just published a paper validating the iPSC derived liver model employed by the...